Skip to content
10-Q

Quarterly Report

ARIAD PHARMACEUTICALS INC

0000884731-16-000114

← back to feed
Filed
Nov 8, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Oct 31, 2016 194.2M sh
Shares Diluted Q3 2016 · Sep 30, 2016 193.23M sh
Shares Diluted Q3 2016 · Sep 30, 2016 195.08M sh
Shares Diluted Q3 2016 · Sep 30, 2015 188.92M sh
Shares Diluted Q3 2016 · Sep 30, 2015 188.46M sh
Capex Q3 2016 · Sep 30, 2016 $39.57M
Capex Q3 2016 · Sep 30, 2015 $4.45M
Long Term Debt Q3 2016 · Sep 30, 2016 $522.91M
Long Term Debt Q3 2016 · Dec 31, 2015 $429.22M
Short Term Debt Q3 2016 · Sep 30, 2016 $30.01M
Short Term Debt Q3 2016 · Dec 31, 2015 $13.87M
Cash And Equivalents Q3 2016 · Sep 30, 2016 $305.04M
Cash And Equivalents Q3 2016 · Dec 31, 2015 $230.89M
Cash And Equivalents Q3 2016 · Sep 30, 2015 $282.19M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $352.69M
Stockholders Equity Q3 2016 · Sep 30, 2016 −$46.35M
Stockholders Equity Q3 2016 · Dec 31, 2015 −$103.14M
Current Liabilities Q3 2016 · Sep 30, 2016 $110.84M
Current Liabilities Q3 2016 · Dec 31, 2015 $132.28M
Total Liabilities Q3 2016 · Sep 30, 2016 $722.94M
Total Liabilities Q3 2016 · Dec 31, 2015 $649.83M
Current Assets Q3 2016 · Sep 30, 2016 $351.24M
Current Assets Q3 2016 · Dec 31, 2015 $275.2M
Total Assets Q3 2016 · Sep 30, 2016 $676.59M
Total Assets Q3 2016 · Dec 31, 2015 $546.69M
Eps Diluted Q3 2016 · Sep 30, 2016 −$0.14
Eps Diluted Q3 2016 · Sep 30, 2016 $0.14
Eps Diluted Q3 2016 · Sep 30, 2015 −$0.29
Eps Diluted Q3 2016 · Sep 30, 2015 −$0.91
Eps Basic Q3 2016 · Sep 30, 2016 −$0.14
Eps Basic Q3 2016 · Sep 30, 2016 $0.15
Eps Basic Q3 2016 · Sep 30, 2015 −$0.29
Eps Basic Q3 2016 · Sep 30, 2015 −$0.91
Sga Expense Q3 2016 · Sep 30, 2016 $26.25M
Sga Expense Q3 2016 · Sep 30, 2016 $96.47M
Sga Expense Q3 2016 · Sep 30, 2015 $36.74M
Sga Expense Q3 2016 · Sep 30, 2015 $118.92M
Rd Expense Q3 2016 · Sep 30, 2016 $43.63M
Rd Expense Q3 2016 · Sep 30, 2016 $130.57M
Rd Expense Q3 2016 · Sep 30, 2015 $48.22M
Rd Expense Q3 2016 · Sep 30, 2015 $126.4M
Net Income Q3 2016 · Sep 30, 2016 −$27.83M
Net Income Q3 2016 · Sep 30, 2016 $28.23M
Net Income Q3 2016 · Sep 30, 2015 −$55.45M
Net Income Q3 2016 · Sep 30, 2015 −$171.29M
Operating Income Q3 2016 · Sep 30, 2016 −$24.99M
Operating Income Q3 2016 · Sep 30, 2016 −$84.52M
Operating Income Q3 2016 · Sep 30, 2015 −$56.38M
Operating Income Q3 2016 · Sep 30, 2015 −$164.68M
Cost Of Revenue Q3 2016 · Sep 30, 2016 $1.13M
Cost Of Revenue Q3 2016 · Sep 30, 2016 $2.73M
Cost Of Revenue Q3 2016 · Sep 30, 2015 $483K
Cost Of Revenue Q3 2016 · Sep 30, 2015 $1.67M
Revenue Q3 2016 · Sep 30, 2016 $46.02M
Revenue Q3 2016 · Sep 30, 2016 $149.74M
Revenue Q3 2016 · Sep 30, 2015 $29.07M
Revenue Q3 2016 · Sep 30, 2015 $82.3M